Abiopharma

🔍 Daniels Eric Joseph (Executive)

Company: PLUS THERAPEUTICS, INC. (PSTV)

Report Date: 2026-04-20

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-20 | Code: A | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 20,000 shares of Stock Option (Right to Buy) at $7.3 per share (Derivative)
  Date: 2026-04-20 | Code: A | Expires: 2036-04-19 | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. One third of the RSUs awarded vest on July 1, 2027, and the remainder of the RSUs vest ratably over the next eight quarters in substantially equal increments.
• F2: One fourth of the options vest on April 20, 2027 and an additional 1/36th of the remaining options vest on each monthly anniversary thereafter in substantially equal increments.